Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNeviā€™a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: TevaIR@Tevapharm.com

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Teva Pharmaceutical Industries Ltd News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,002.60100.80-1.24%
CAC 407,988.9647.050.59%
DAX 4022,667.76338.991.52%
Dow JONES (US)41,445.0511.570.03%
FTSE 1008,540.9744.980.53%
HKSE23,600.31181.83-0.76%
NASDAQ17,711.62275.531.58%
Nikkei 22536,819.0925.980.07%
NZX 50 Index12,249.55161.42-1.30%
S&P 5005,616.0643.990.79%
S&P/ASX 2007,786.20103.90-1.32%
SSE Composite Index3,371.927.90-0.23%

Market Movers